Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation




Majala, Susanna; Elonen, Lauri; Kaprio, Tuomas; Vesterinen, Tiina; Kauhanen, Saila; Sammalkorpi, Henna; Parviainen, Helka; Schalin-Jäntti, Camilla; Schildt, Jukka; Laukkarinen, Johanna; Ahola, Reea; Nieminen, Lasse; Rinta-Kiikka, Irina; Ronkainen, Johanna; Sipilä, Kalle; Nortunen, Minna; Karjula, Heikki; Huhta, Heikki; Pohjanen, Vesa-Matti; Mäkinen, Markus; Söderström, Mirvamaaria; Kemppainen, Jukka; Mrena, Johanna; Kuopio, Teijo; Koivula, Anna-Stiina; Rantanen, Tuomo; Pulkkinen, Jukka; Sironen, Reijo; Haglund, Caj; Arola, Johanna; Seppänen, Hanna

PublisherOxford University Press (OUP)

2025

British Journal of Surgery

znaf197

112

10

0007-1323

1365-2168

DOIhttps://doi.org/10.1093/bjs/znaf197

https://doi.org/10.1093/bjs/znaf197



Pancreatic neuroendocrine tumours (panNETs) comprise a heterogeneous tumour group with unresolved optimal treatment.



This research was funded by the Academy of Finland, the Sigrid Juselius Foundation, the Cancer Foundation Finland, and Finska Läkaresällskapet, and through State Research Funding.


Last updated on 2025-22-10 at 15:57